Sela M - Search Results

1

Roles for growth factors in cancer progression.

Witsch E, Sela M, Yarden Y. Witsch E, et al. Among authors: sela m. Physiology (Bethesda). 2010 Apr;25(2):85-101. doi: 10.1152/physiol.00045.2009. Physiology (Bethesda). 2010. PMID: 20430953 Free PMC article. Review.

2

Synergistic down-regulation of receptor tyrosine kinases by combinations of mAbs: implications for cancer immunotherapy.

Friedman LM, Rinon A, Schechter B, Lyass L, Lavi S, Bacus SS, Sela M, Yarden Y. Friedman LM, et al. Among authors: sela m. Proc Natl Acad Sci U S A. 2005 Feb 8;102(6):1915-20. doi: 10.1073/pnas.0409610102. Epub 2005 Jan 31. Proc Natl Acad Sci U S A. 2005. PMID: 15684082 Free PMC article.

3

Persistent elimination of ErbB-2/HER2-overexpressing tumors using combinations of monoclonal antibodies: relevance of receptor endocytosis.

Ben-Kasus T, Schechter B, Lavi S, Yarden Y, Sela M. Ben-Kasus T, et al. Among authors: sela m. Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3294-9. doi: 10.1073/pnas.0812059106. Epub 2009 Feb 13. Proc Natl Acad Sci U S A. 2009. PMID: 19218427 Free PMC article.

4

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors.

Klapper LN, Glathe S, Vaisman N, Hynes NE, Andrews GC, Sela M, Yarden Y. Klapper LN, et al. Among authors: sela m. Proc Natl Acad Sci U S A. 1999 Apr 27;96(9):4995-5000. doi: 10.1073/pnas.96.9.4995. Proc Natl Acad Sci U S A. 1999. PMID: 10220407 Free PMC article.

5

Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.

Klapper LN, Kirschbaum MH, Sela M, Yarden Y. Klapper LN, et al. Among authors: sela m. Adv Cancer Res. 2000;77:25-79. Adv Cancer Res. 2000. PMID: 10549355 Review.

6

Cancer therapeutic antibodies come of age: targeting minimal residual disease.

Ben-Kasus T, Schechter B, Sela M, Yarden Y. Ben-Kasus T, et al. Among authors: sela m. Mol Oncol. 2007 Jun;1(1):42-54. doi: 10.1016/j.molonc.2007.01.003. Epub 2007 Mar 14. Mol Oncol. 2007. PMID: 19383286 Free PMC article. Review.

7

Generation and characterization of peptide mimotopes specific for anti ErbB-2 monoclonal antibodies.

Witsch EJ, Mahlknecht G, Wakim J, Sertchook R, Bublil E, Yarden Y, Sela M. Witsch EJ, et al. Among authors: sela m. Int Immunol. 2011 Jun;23(6):391-403. doi: 10.1093/intimm/dxr028. Epub 2011 May 19. Int Immunol. 2011. PMID: 21602175 Free PMC article.

8

Aptamer to ErbB-2/HER2 enhances degradation of the target and inhibits tumorigenic growth.

Mahlknecht G, Maron R, Mancini M, Schechter B, Sela M, Yarden Y. Mahlknecht G, et al. Among authors: sela m. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8170-5. doi: 10.1073/pnas.1302594110. Epub 2013 Apr 29. Proc Natl Acad Sci U S A. 2013. PMID: 23630281 Free PMC article.

9

Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2.

Maron R, Schechter B, Mancini M, Mahlknecht G, Yarden Y, Sela M. Maron R, et al. Among authors: sela m. Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):15389-94. doi: 10.1073/pnas.1313857110. Epub 2013 Sep 3. Proc Natl Acad Sci U S A. 2013. PMID: 24003140 Free PMC article.

10

Examination of HER3 targeting in cancer using monoclonal antibodies.

Gaborit N, Abdul-Hai A, Mancini M, Lindzen M, Lavi S, Leitner O, Mounier L, Chentouf M, Dunoyer S, Ghosh M, Larbouret C, Chardès T, Bazin H, Pèlegrin A, Sela M, Yarden Y. Gaborit N, et al. Among authors: sela m. Proc Natl Acad Sci U S A. 2015 Jan 20;112(3):839-44. doi: 10.1073/pnas.1423645112. Epub 2015 Jan 6. Proc Natl Acad Sci U S A. 2015. PMID: 25564668 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

644 results

Search Page

Filters